Drugs / Mineral trioxide aggregate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT05554952 Background | Nov 2021 → Nov 2023 | dental pulp calcification | Minia University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mineral trioxide aggregate | “Mineral trioxide aggregate (MTA) is composed of Portland cement, with 4:1 addition of bismuth oxide added so that the material can be detected on a radiograph.” NCT05554952 ↗ |
| Known as | MTA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05554952 ↗ |
| Modality | Other / unclassified | “Mineral trioxide aggregate (MTA) is composed of Portland cement, with 4:1 addition of bismuth oxide added so that the material can be detected on a radiograph.” NCT05554952 ↗ |